Ironwood Pharmaceuticals | IRWD - 债务

股票价格
4.22
每天变化
0 0%
每月一次
17.22%
每年
495.04%
Q2 预测
4.13


金融业
股票价格
USD
资产
USD 434.57M
现金及等价物
USD 220.47M
销售成本
USD 29.83M
流动资产
USD 332.29M
流动负债
USD 236.31M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.24
股本和储备
USD -217.14M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 660.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 106.51M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.24M
应收帐款人
USD 81.89M


债务 更改 日
Acadia Pharmaceuticals USD 52.19M 2.62M 2025-12
Agios Pharmaceuticals USD 40.21M 4.31M 2025-12
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Almirall EUR 342.86M 61.94M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amarin USD 0 0 2025-03
Ardelyx USD 207.61M 968K 2025-09
Astellas Pharma JPY 831.43B 83.94B 2025-03
AstraZeneca USD 33.92B 4.3B 2026-03
Charles River Laboratories USD 2.57B 58.23M 2025-12
Coherus Biosciences USD 294.92M 1.25M 2025-03
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Halozyme Therapeutics USD 2.14B 631.87M 2025-12
Incyte USD 39.43M 982K 2026-03
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Lexicon Pharmaceuticals USD 99.51M 243K 2023-12
MacroGenics USD 37.01M 238K 2025-09
Moderna USD 1.31B 571M 2025-12
Myriad Genetics USD 59.3M 19.7M 2025-03
Pacira USD 367.66M 4.53M 2026-03
PTC Therapeutics USD 286.94M 2.42B 2026-03
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sarepta Therapeutics USD 1.04B 210.44M 2025-12
Takeda JPY 4.85T 208B 2025-12
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12